SCHEMBL28368651

SCHEMBL28368651

O=C(c1ccc(F)cc1)c1cnc(C2=CCN(C(=O)O)CC2)nc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 5/20 0.44
▸ ALDH1A1 P00352 5/20 0.44
▸ RAB9A P51151 4/20 0.44
▸ HPGD P15428 3/20 0.44
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ ALOX15 P16050 2/20 0.44
▸ MAPT P10636 2/20 0.44
▸ CASP3 P42574 1/20 0.44
▸ SENP8 Q96LD8 1/20 0.44
▸ SENP7 Q9BQF6 1/20 0.44
▸ SENP6 Q9GZR1 1/20 0.44
▸ RXFP1 Q9HBX9 1/20 0.42
▸ KDM4E B2RXH2 2/20 0.40
▸ TSHR P16473 2/20 0.40
▸ USP2 O75604 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ SIGMAR1 Q99720 5/20 0.40
▸ NAMPT P43490 1/20 0.40
▸ TP53 P04637 2/20 0.40
▸ MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28368267 0.87 VNN1 (0.44) NPC1ALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL28368042 0.85 KDM4E (0.40) NPC1ALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL28884398 0.84 RXFP1 (0.45) ALDH1A1RAB9AHPGDALOX15MAPT
SCHEMBL28365163 0.84 TRPV1 (0.41) ALDH1A1MAPTSIGMAR1VNN1LMNA
SCHEMBL20760484 0.83 GRM1 (0.60) NAMPTGRM5GRM1
SCHEMBL4602817 0.78 ALDH1A1 (0.66) NPC1ALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL18009528 0.77 ALDH1A1 (0.41) NPC1ALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL28966541 0.76 TRPV1 (0.45) ALDH1A1SMN1; SMN2
SCHEMBL10317879 0.75 ALDH1A1 (0.54) NPC1ALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL28443996 0.74 TRPV1 (0.45) NPC1ALDH1A1RAB9AHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117098760-A Compositions and methods for treating KIT and PDGFRA mediated diseases 缆图药品公司 2023-11-21 — — CN disclosed
CN-110891953-B Pyrrolotriazines derivatives, preparation method and application thereof 浙江海正药业股份有限公司 2022-07-12 — — CN disclosed
CN-110891953-A Pyrrolotriazines derivatives, preparation method and application thereof 浙江海正药业股份有限公司 2020-03-17 — — CN disclosed
Send feedback